Ekso Bionics Holdings (EKSO) Receivables - Net (2016 - 2026)
Ekso Bionics Holdings has reported Receivables - Net over the past 13 years, most recently at $7.3 million for Q4 2025.
- On a quarterly basis, Receivables - Net rose 0.97% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 0.97% increase, with the full-year FY2025 number at $7.3 million, up 0.97% from a year prior.
- Receivables - Net reached $7.3 million in Q4 2025 per EKSO's latest filing, up from $6.0 million in the prior quarter.
- The five-year high for Receivables - Net was $7.3 million in Q4 2025, with the low at $2.3 million in Q1 2021.
- The 5-year median for Receivables - Net is $4.9 million (2023), against an average of $5.1 million.
- Peak YoY movement for Receivables - Net: surged 72.84% in 2023, then tumbled 30.48% in 2025.
- Tracing EKSO's Receivables - Net over 5 years: stood at $4.7 million in 2021, then dropped by 0.79% to $4.6 million in 2022, then rose by 22.05% to $5.6 million in 2023, then rose by 28.22% to $7.2 million in 2024, then rose by 0.97% to $7.3 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $7.3 million, $6.0 million, and $4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.